Literature DB >> 19117390

Dynamics of "flap" structures in three HIV-1 protease/inhibitor complexes probed by total chemical synthesis and pulse-EPR spectroscopy.

Vladimir Yu Torbeev1, H Raghuraman, Kalyaneswar Mandal, Sanjib Senapati, Eduardo Perozo, Stephen B H Kent.   

Abstract

The unliganded form of nitroxide spin-labeled HIV-1 protease and three different complexes with inhibitors were studied by pulse-EPR spectroscopy to determine "interflap" distance distributions in solution. In the unliganded enzyme, we observed a rather broad distribution with three maxima corresponding to three flap conformers; the principal form is a "semiopen/semiopen" conformer. In the complexes with inhibitors, the dominant conformer is an asymmetric "closed/semiopen" form. Moreover, the distance distribution profile is significantly varied among the different inhibitors, which mimic different species on the reaction coordinate for enzyme catalyzed proteolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117390     DOI: 10.1021/ja806526z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  20 in total

1.  Protein conformational dynamics in the mechanism of HIV-1 protease catalysis.

Authors:  Vladimir Yu Torbeev; H Raghuraman; Donald Hamelberg; Marco Tonelli; William M Westler; Eduardo Perozo; Stephen B H Kent
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-08       Impact factor: 11.205

2.  Spin labeling and Double Electron-Electron Resonance (DEER) to Deconstruct Conformational Ensembles of HIV Protease.

Authors:  Thomas M Casey; Gail E Fanucci
Journal:  Methods Enzymol       Date:  2015-09-01       Impact factor: 1.600

3.  Pulsed EPR characterization of HIV-1 protease conformational sampling and inhibitor-induced population shifts.

Authors:  Zhanglong Liu; Thomas M Casey; Mandy E Blackburn; Xi Huang; Linh Pham; Ian Mitchelle S de Vera; Jeffrey D Carter; Jamie L Kear-Scott; Angelo M Veloro; Luis Galiano; Gail E Fanucci
Journal:  Phys Chem Chem Phys       Date:  2016-02-17       Impact factor: 3.676

4.  Effects of PRE and POST therapy drug-pressure selected mutations on HIV-1 protease conformational sampling.

Authors:  Jeffrey D Carter; Estrella G Gonzales; Xi Huang; Adam N Smith; Ian Mitchelle S de Vera; Peter W D'Amore; James R Rocca; Maureen M Goodenow; Ben M Dunn; Gail E Fanucci
Journal:  FEBS Lett       Date:  2014-06-28       Impact factor: 4.124

5.  Small molecule regulation of protein conformation by binding in the Flap of HIV protease.

Authors:  Theresa Tiefenbrunn; Stefano Forli; Michael M Baksh; Max W Chang; Meaghan Happer; Ying-Chuan Lin; Alexander L Perryman; Jin-Kyu Rhee; Bruce E Torbett; Arthur J Olson; John H Elder; M G Finn; C David Stout
Journal:  ACS Chem Biol       Date:  2013-03-29       Impact factor: 5.100

Review 6.  The early years of retroviral protease crystal structures.

Authors:  Maria Miller
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

7.  The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics.

Authors:  Xi Huang; Manuel D Britto; Jamie L Kear-Scott; Christopher D Boone; James R Rocca; Carlos Simmerling; Robert Mckenna; Michael Bieri; Paul R Gooley; Ben M Dunn; Gail E Fanucci
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

Review 8.  Limiting assumptions in structure-based design: binding entropy.

Authors:  Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2012-01-03       Impact factor: 3.686

9.  Method to Predict Crowding Effects by Postprocessing Molecular Dynamics Trajectories: Application to the Flap Dynamics of HIV-1 Protease.

Authors:  Sanbo Qin; David D L Minh; J Andrew McCammon; Huan-Xiang Zhou
Journal:  J Phys Chem Lett       Date:  2009-11-09       Impact factor: 6.475

10.  Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility.

Authors:  Jamie L Kear; Mandy E Blackburn; Angelo M Veloro; Ben M Dunn; Gail E Fanucci
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.